MedTrace Logo

Scandinavian Cohort Study for Optimal Use of Portal Vein Embolization

NCT04182386 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2022-03-31

No results posted yet for this study

Summary

Several aspects on the use of portal vein embolization (PVE) are poorly studied and todays recommendations are based on low-grade evidence. In this Scandinavian multicenter cohort study we will study some of the controversial aspects on the use of PVE to try to provide clearer answers on its optimal use. Six tertiary university hospital hepatobiliary units in Sweden, Norway and Denmark participate and contribute with all PVE procedures performed at their units during the study period. We will then study several aspects PVE technique in relation to induced hypertrophy and surgical outcome.

Conditions

  • Hepatic Neoplasm

Interventions

PROCEDURE

Portal vein embolization

Selective preoperative portal vein embolization

Sponsors & Collaborators

  • Karolinska University Hospital

    lead OTHER

Principal Investigators

  • Ernesto Sparrelid, MD PhD · Karolinska University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-01
Primary Completion
2021-12-31
Completion
2022-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04182386 on ClinicalTrials.gov